Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
27.15
-0.37 (-1.34%)
At close: Dec 26, 2025, 4:00 PM EST
27.13
-0.02 (-0.07%)
After-hours: Dec 26, 2025, 4:10 PM EST
KMTS Revenue
Kestra Medical Technologies had revenue of $22.57M in the quarter ending October 31, 2025, with 53.40% growth. This brings the company's revenue in the last twelve months to $74.26M, up 62.06% year-over-year. In the fiscal year ending April 30, 2025, Kestra Medical Technologies had annual revenue of $59.82M with 115.05% growth.
Revenue (ttm)
$74.26M
Revenue Growth
+62.06%
P/S Ratio
14.73
Revenue / Employee
$225,030
Employees
330
Market Cap
1.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 59.82M | 32.00M | 115.05% |
| Apr 30, 2024 | 27.81M | 20.18M | 264.53% |
| Apr 30, 2023 | 7.63M | - | - |
| Apr 30, 2021 | - | - | - |
| Apr 30, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
KMTS News
- 15 days ago - Kestra Medical Technologies, Ltd. (KMTS) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results - GlobeNewsWire
- 23 days ago - Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results - GlobeNewsWire
- 24 days ago - Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares - GlobeNewsWire
- 25 days ago - Kestra Medical Technologies, Ltd. Announces Primary Public Offering of Common Shares - GlobeNewsWire
- 25 days ago - Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results - GlobeNewsWire
- 6 weeks ago - Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra's ASSURE Device - GlobeNewsWire
- 7 weeks ago - Kestra Medical Technologies to Present Late-Breaking ACE-PAS Trial Results at AHA 2025, Showcasing Next-Generation Wearable Defibrillator System - GlobeNewsWire